Company

Verici Dx plc

Headquarters: Penarth, United Kingdom

Employees: 10

CEO: Ms. Sara Barrington A.C.A., A.C.I.M.

LSE: VRCI

Market Cap

£11.0 Million

GBP as of Jan. 1, 2026

US$14.8 Million

Market Cap History

Verici Dx plc Categories

United Kingdom Healthcare Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Verici Dx plc market capitalization over time

Evolution of Verici Dx plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Verici Dx plc

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector:
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Detailed Description

Verici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Stocks & Indices

Verici Dx plc has the following listings and related stock indices.


Stock: LSE: VRCI

Details

Headquarters:

Avon House

19 Stanwell Road

Penarth, CF64 2EZ

United Kingdom

Phone: 44 207 9338780